Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study

被引:11
作者
Koppara, Tobias [1 ,2 ,3 ]
Tada, Tomohisa [1 ]
Xhepa, Erion [1 ,2 ]
Kutner, Sebastian [1 ,2 ]
Byrne, Robert A. [1 ,2 ]
Ibrahim, Tareq [3 ]
Laugwitz, Karl -Ludwig [2 ,3 ]
Kastrati, Adnan [1 ,2 ]
Joner, Michael [1 ,2 ]
机构
[1] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany
[2] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med Cardiol 1, Munich, Germany
关键词
Percutaneous coronary intervention; Biodegradable polymer coating; Optical coherence tomography; VS. DURABLE POLYMER; FOLLOW-UP; PORCINE MODEL; CORONARY; THROMBOSIS; RESTENOSIS; INTERVENTION; IMPLANTATION; PATHOLOGY; COATINGS;
D O I
10.1016/j.ijcard.2018.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Drug-eluting stents with biodegradable polymer coatings have shown promising outcomes in randomised studies. Methods: We compared neointimal healing patterns including strut coverage and assessed neointimal maturity using a novel algorithm in coronary lesions treated with sirolimus-eluting stents with biodegradable polymer coating (BP-SES) or everolimus eluting stents with permanent polymer coating (PP-EES) using optical coherence tomography after 6months. Results: A total of 39 patients were randomised to BP-SES (n = 19) or PP-EES (n = 20) for the treatment of coronary lesions. Of those, 29 patients (14 BP-SES and 15 PP-EES) underwent optical coherence tomography (OCT) and angiography at 6-month follow-up. Tissue coverage and apposition were assessed in a total of 6162 struts (BP-SES, n = 2889; PP-EES, n = 3273). Neointimal maturity was assessed in 3672 neointimal regions above struts using grey scale intensity analysis. OCT analysis showed neointimal coverage of 2433 (BP-SES) vs. 2702 (PP-EES) struts (84.2% vs. 82.6%, p = 0.70), whereas the remainder was uncovered after 6months. Mean neointimal thickness did not differ significantly between groups (54.3 +/- 7.8 mu m vs. 80 +/- 14.6 mu m, p = 0.12). The rate of malapposed struts was comparable between groups (1.3% vs. 2.2%, p = 0.27). Grey scale signal intensity analysis showed mature tissue coverage of struts in 46.2% in BP-SES vs. 31.8% in PP-EES (p = 0.31) of neointimal regions. Conclusion: The present study showed comparable early vascular healing response characterised by neointimal coverage with mainly immature neointima in both BP-SES and PP-EES. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 38 条
[21]   One Step Forward and Two Steps Back With Drug-Eluting-Stents From Preventing Restenosis to Causing Late Thrombosis and Nouveau Atherosclerosis [J].
Nakazawa, Gaku ;
Vorpahl, Marc ;
Finn, Aloke V. ;
Narula, Jagat ;
Virmani, Renu .
JACC-CARDIOVASCULAR IMAGING, 2009, 2 (05) :625-628
[22]   Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment [J].
Otsuka, Fumiyuki ;
Byrne, RobertA. ;
Yahagi, Kazuyuki ;
Mori, Hiroyoshi ;
Ladich, Elena ;
Fowler, David R. ;
Kutys, Robert ;
Xhepa, Erion ;
Kastrati, Adnan ;
Virmani, Renu ;
Joner, Michael .
EUROPEAN HEART JOURNAL, 2015, 36 (32) :2147-U29
[23]   Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans [J].
Otsuka, Fumiyuki ;
Vorpahl, Marc ;
Nakano, Masataka ;
Foerst, Jason ;
Newell, John B. ;
Sakakura, Kenichi ;
Kutys, Robert ;
Ladich, Elena ;
Finn, Aloke V. ;
Kolodgie, Frank D. ;
Virmani, Renu .
CIRCULATION, 2014, 129 (02) :211-223
[24]   Stent Thrombosis With Drug-Eluting Stents Is the Paradigm Shifting? [J].
Palmerini, Tullio ;
Biondi-Zoccai, Giuseppe ;
Della Riva, Diego ;
Mariani, Andrea ;
Genereux, Philippe ;
Branzi, Angelo ;
Stone, Gregg W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (21) :1915-1921
[25]   Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial [J].
Pilgrim, Thomas ;
Heg, Dik ;
Roffi, Marco ;
Tuller, David ;
Muller, Olivier ;
Vuilliomenet, Andre ;
Cook, Stephane ;
Weilenmann, Daniel ;
Kaiser, Christoph ;
Jamshidi, Peiman ;
Fahrni, Therese ;
Moschovitis, Aris ;
Noble, Stephane ;
Eberli, Franz R. ;
Wenaweser, Peter ;
Juni, Peter ;
Windecker, Stephan .
LANCET, 2014, 384 (9960) :2111-2122
[26]   Lower risk of stent thrombosis and restenosis with unrestricted use of onew-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR) [J].
Sarno, Giovanna ;
Lagerqvist, Bo ;
Frobert, Ole ;
Nilsson, Johan ;
Olivecrona, Goran ;
Omerovic, Elmir ;
Saleh, Nawzad ;
Venetzanos, Dimitris ;
James, Stefan .
EUROPEAN HEART JOURNAL, 2012, 33 (05) :606-613
[27]  
Serruys Patrick W, 2006, EuroIntervention, V2, P286
[28]   Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomized, Noninferiority Trial [J].
Serruys, Patrick W. ;
Farooq, Vasim ;
Kalesan, Bindu ;
de Vries, Ton ;
Buszman, Pawel ;
Linke, Axel ;
Ischinger, Thomas ;
Klauss, Volker ;
Eberli, Franz ;
Wijns, William ;
Morice, Marie Claude ;
Di Mario, Carlo ;
Corti, Roberto ;
Antoni, Diethmar ;
Sohn, Hae Y. ;
Eerdmans, Pedro ;
Rademaker-Havinga, Tessa ;
van Es, Gerrit-Anne ;
Meier, Bernhard ;
Jueni, Peter ;
Windecker, Stephan .
JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (08) :777-789
[29]   Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents [J].
Serruys, Patrick W. ;
Silber, Sigmund ;
Garg, Scot ;
van Geuns, Robert Jan ;
Richardt, Gert ;
Buszman, Pawel E. ;
Kelbaek, Henning ;
van Boven, Adrianus Johannes ;
Hofma, Sjoerd H. ;
Linke, Axel ;
Klauss, Volker ;
Wijns, William ;
Macaya, Carlos ;
Garot, Philippe ;
DiMario, Carlo ;
Manoharan, Ganesh ;
Kornowski, Ran ;
Ischinger, Thomas ;
Bartorelli, Antonio ;
Ronden, Jacintha ;
Bressers, Marco ;
Gobbens, Pierre ;
Negoita, Manuela ;
van Leeuwen, Frank ;
Windecker, Stephan .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02) :136-146
[30]   Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V-(R)) [J].
Sheiban, Imad ;
Villata, Gianluca ;
Bollati, Mario ;
Sillano, Dario ;
Lotrionte, Marzia ;
Biondi-Zoccai, Giuseppe .
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (01) :31-38